ConductScience.org, home

Trial · NCT03806452

Outcomes29

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Patients Achieving at Least a 30% Decrease in ACR Baseline Value6 months3 patients in the hydroxycarbamide arm and 2 patients in the placebo arm do not have any measure at 6 months and so were not part of this analysisParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAbsolute Mean Changes in eGFR Value6 monthsml/min/1.73m2MEAN
SECONDARYAbsolute Mean Changes in ACR Value6 monthsmg/mmolMEAN
SECONDARYProportion of Patients With a Shift From Macroalbuminuria to Microalbuminuria6 monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYProportion of Patients With a Shift From Microalbuminuria to Normoalbuminuria6 monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYProportion of Patients With a Shift From Macroalbuminuria to Normoalbuminuria6 monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYProportion of Patients With a Shift From Microalbuminuria to Macroalbuminuria6 monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAbsolute Mean Changes of Systolic Blood Pressure6 monthsmmHgMEAN
SECONDARYAbsolute Mean Changes of Body Weight6 monthskgMEAN
SECONDARYAbsolute Mean Changes of Diastolic Blood Pressure6 monthsmmHgMEAN
SECONDARYAbsolute Mean Changes of Heart Rate Measure6 monthsbeats/minuteMEAN
SECONDARYAbsolute Mean Changes in White Blood Cells Count6 monthscells/mm3MEAN
SECONDARYAbsolute Mean Changes in Platelets Count6 months10^9 platelets per literMEAN
SECONDARYAbsolute Mean Changes in Mean Corpuscular Volume6 monthsfLMEAN
SECONDARYAbsolute Mean Changes in Mean Corpuscular Haemoglobin Concentration6 monthsg/LMEAN
SECONDARYAbsolute Mean Changes in Mean Corpuscular Haemoglobin6 monthspgMEAN
SECONDARYAbsolute Mean Changes in Hemoglobin Count6 monthsg/LMEAN
SECONDARYAbsolute Mean Changes in Foetal Hemoglobin Count6 monthspercentage of hemoglobinMEAN
SECONDARYAbsolute Mean Changes in Free Hemoglobin Count6 months and 12 months for responder patients willing to continue the study after month 6.
SECONDARYAbsolute Mean Changes in Dense Red Blood Cells Percentage6 months and 12 months for responder patients willing to continue the study after month 6.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03806452/outcomes